Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
2000 1
2002 1
2003 1
2004 4
2005 1
2006 1
2007 1
2008 3
2009 2
2010 1
2011 2
2012 1
2013 1
2014 2
2015 3
2016 3
2017 2
2019 3
2020 3
2021 1
2023 2
2024 8
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for swinkels a
Search for Swinkles A instead (1 results)
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.
Sonke GS, van Ommen-Nijhof A, Wortelboer N, van der Noort V, Swinkels ACP, Blommestein HM, Guerrero Paez C, Mol L, Beeker A, Beelen K, Hamming LC, Heijns JB, Honkoop AH, de Jong PC, van Rossum-Schornagel QC, van Schaik-van de Mheen C, Tol J, Tromp-van Driel CS, Vrijaldenhoven S, van Leeuwen-Stok AE, Konings IR, Jager A; SONIA Study Consortium. Sonke GS, et al. Among authors: swinkels acp. Nature. 2024 Dec;636(8042):474-480. doi: 10.1038/s41586-024-08035-2. Epub 2024 Nov 27. Nature. 2024. PMID: 39604725 Clinical Trial.
Flumequine, a fluoroquinolone in disguise.
Swinkels AF, Fischer EAJ, Korving L, Christodoulou R, Wagenaar JA, Zomer AL. Swinkels AF, et al. NPJ Antimicrob Resist. 2024 Oct 3;2(1):28. doi: 10.1038/s44259-024-00044-5. NPJ Antimicrob Resist. 2024. PMID: 39843624 Free PMC article.
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.
Lammers SWM, Geurts SME, Hermans KEPE, Kooreman LFS, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, Honkoop AH, van den Berkmortel FWPJ, de Roos WK, Linn SC, Imholz ALT, Vriens IJH, Tjan-Heijnen VCG; Dutch Breast Cancer Research Group (BOOG) for the DATA investigators. Lammers SWM, et al. Among authors: swinkels acp. ESMO Open. 2025 Feb;10(2):104154. doi: 10.1016/j.esmoop.2025.104154. Epub 2025 Feb 7. ESMO Open. 2025. PMID: 39921934 Free PMC article. Clinical Trial.
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.
Tjan-Heijnen VCG, van Hellemond IEG, Peer PGM, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, De Graaf H, Honkoop AH, Erdkamp FLG, van den Berkmortel FWPJ, de Boer M, de Roos WK, Linn SC, Imholz ALT, Seynaeve CM; Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators. Tjan-Heijnen VCG, et al. Among authors: swinkels acp. Lancet Oncol. 2017 Nov;18(11):1502-1511. doi: 10.1016/S1470-2045(17)30600-9. Epub 2017 Oct 12. Lancet Oncol. 2017. PMID: 29031778 Clinical Trial.
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
van Hellemond IEG, Smorenburg CH, Peer PGM, Swinkels ACP, Seynaeve CM, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, van den Berkmortel FWPJ, de Roos WK, Linn SC, Imholz ALT, de Boer M, Tjan-Heijnen VCG; Dutch Breast Cancer Research Group (BOOG). van Hellemond IEG, et al. Among authors: swinkels acp. Breast Cancer Res Treat. 2020 Apr;180(3):675-685. doi: 10.1007/s10549-020-05567-9. Epub 2020 Mar 2. Breast Cancer Res Treat. 2020. PMID: 32124136 Free PMC article. Clinical Trial.
45 results